Financial Information for the Company and Its Subsidiaries (Tables)

6 Months Ended

Jun. 30, 2015

Condensed Financial Information of Parent Company Only Disclosure [Abstract]

Condensed Consolidating Balance Sheet

Condensed Consolidating Balance Sheet - June 30, 2015 (In thousands)
	Parent Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Assets
Current assets:
Cash and cash equivalents	$	43,658	$	27,112	$	55,519	$	—		$	126,289
Restricted cash and marketable securities	—		—		11,581		—			11,581
Accounts receivable, net	—		140,678		119,194		—			259,872
Supplies inventory	—		288		20,697		—			20,985
Prepaid and other current assets	31,245		31,467		25,379		(4,234		)	83,857
Total current assets	74,903		199,545		232,370		(4,234		)	502,584
Property and equipment, net	12,786		8,661		167,308		—			188,755
Investments in and receivables from unconsolidated affiliates	4,086,890		1,698,299		—		(5,701,510		)	83,679
Goodwill	—		1,551,050		—		2,034,971			3,586,021
Intangible assets, net	64,165		1,215,583		2,629		—			1,282,377
Other assets	3,735		1,001		19,880		—			24,616
Total assets	$	4,242,479	$	4,674,139	$	422,187	$	(3,670,773	)	$	5,668,032
Liabilities and Equity
Current liabilities:
Current portion of long-term debt	$	8,700	$	—	$	11,078	$	—		$	19,778
Accounts payable	1,956		2,527		27,372		(3,341		)	28,514
Accrued salaries and benefits	26,405		100,159		15,155		—			141,719
Accrued interest	29,793		—		11		—			29,804
Other accrued liabilities	7,867		49,384		40,791		(893		)	97,149
Total current liabilities	74,721		152,070		94,407		(4,234		)	316,964
Long-term debt	2,202,600		—		55,051		(27,968		)	2,229,683
Deferred income taxes	219,566		404,101		—		—			623,667
Other long-term liabilities	7,934		64,586		19,434		—			91,954
Intercompany payable	—		1,228,157		—		(1,228,157		)	—
Noncontrolling interests – redeemable	—		—		64,511		120,666			185,177
Equity:
Total AmSurg Corp. equity	1,737,658		2,825,225		138,497		(2,963,722		)	1,737,658
Noncontrolling interests – non-redeemable	—		—		50,287		432,642			482,929
Total equity	1,737,658		2,825,225		188,784		(2,531,080		)	2,220,587
Total liabilities and equity	$	4,242,479	$	4,674,139	$	422,187	$	(3,670,773	)	$	5,668,032

Condensed Consolidating Balance Sheet - December 31, 2014 (In thousands)
	Parent Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Assets
Current assets:
Cash and cash equivalents	$	134,351	$	23,471	$	50,257	$	—		$	208,079
Restricted cash and marketable securities	—		—		10,219		—			10,219
Accounts receivable, net	—		123,772		109,281		—			233,053
Supplies inventory	—		301		19,673		—			19,974
Prepaid and other current assets	47,997		58,388		13,795		(4,818		)	115,362
Total current assets	182,348		205,932		203,225		(4,818		)	586,687
Property and equipment, net	10,391		9,972		160,085		—			180,448
Investments in and receivables from unconsolidated affiliates	3,912,804		1,587,881		—		(5,425,210		)	75,475
Goodwill	—		1,490,981		—		1,890,168			3,381,149
Intangible assets, net	67,678		1,203,218		2,983		—			1,273,879
Other assets	3,323		943		23,086		(1,466		)	25,886
Total assets	$	4,176,544	$	4,498,927	$	389,379	$	(3,541,326	)	$	5,523,524
Liabilities and Equity
Current liabilities:
Current portion of long-term debt	$	8,700	$	—	$	10,126	$	—		$	18,826
Accounts payable	1,849		35		31,781		(4,080		)	29,585
Accrued salaries and benefits	25,035		101,395		13,614		—			140,044
Accrued interest	29,621		—		23		—			29,644
Other accrued liabilities	8,051		44,305		16,368		(738		)	67,986
Total current liabilities	73,256		145,735		71,912		(4,818		)	286,085
Long-term debt	2,206,950		—		53,648		(28,412		)	2,232,186
Deferred income taxes	209,400		425,546		—		(1,466		)	633,480
Other long-term liabilities	7,391		63,616		18,436		—			89,443
Intercompany payable	—		1,219,979		8,010		(1,227,989		)	—
Noncontrolling interests – redeemable	—		—		63,544		120,555			184,099
Equity:
Total AmSurg Corp. equity	1,679,547		2,644,051		130,206		(2,774,257		)	1,679,547
Noncontrolling interests – non-redeemable	—		—		43,623		375,061			418,684
Total equity	1,679,547		2,644,051		173,829		(2,399,196		)	2,098,231
Total liabilities and equity	$	4,176,544	$	4,498,927	$	389,379	$	(3,541,326	)	$	5,523,524

Condensed Consolidating Statement of Operations

Condensed Consolidating Statement of Earnings - For the Three Months Ended June 30, 2015 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Net revenue	$	7,079		$	329,579		$	314,780	$	(9,488	)	$	641,950
Operating expenses:
Salaries and benefits	15,511			228,618			76,391		(124		)	320,396
Supply cost	—			489			45,335		(34		)	45,790
Other operating expenses	5,783			42,099			66,450		(9,330		)	105,002
Transaction costs	324			1,658			—		—			1,982
Depreciation and amortization	1,056			14,617			7,939		—			23,612
Total operating expenses	22,674			287,481			196,115		(9,488		)	496,782
Loss on deconsolidation	—			(3,035		)	—		—			(3,035		)
Equity in earnings of unconsolidated affiliates	76,931			64,513			—		(137,455		)	3,989
Operating income	61,336			103,576			118,665		(137,455		)	146,122
Interest expense, net	11,978			17,624			580		—			30,182
Earnings from operations before income taxes	49,358			85,952			118,085		(137,455		)	115,940
Income tax expense	15,683			9,021			489		—			25,193
Net earnings	33,675			76,931			117,596		(137,455		)	90,747
Net earnings attributable to noncontrolling interests	—			—			57,072		—			57,072
Net earnings attributable to AmSurg Corp. shareholders	33,675			76,931			60,524		(137,455		)	33,675
Preferred stock dividends	(2,264		)	—			—		—			(2,264		)
Net earnings attributable to AmSurg Corp. common shareholders	$	31,411		$	76,931		$	60,524	$	(137,455	)	$	31,411

Condensed Consolidating Statement of Earnings - For the Six Months Ended June 30, 2015 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Net revenue	$	14,170		$	615,158		$	601,409		$	(18,342	)	$	1,212,395
Operating expenses:
Salaries and benefits	33,154			440,219			149,454			(252		)	622,575
Supply cost	—			885			87,523			(34		)	88,374
Other operating expenses	12,417			71,710			129,501			(18,056		)	195,572
Transaction costs	592			2,861			—			—			3,453
Depreciation and amortization	1,890			28,924			15,616			—			46,430
Total operating expenses	48,053			544,599			382,094			(18,342		)	956,404
Loss on deconsolidation	(188		)	(3,223		)	(35		)	188			(3,258		)
Equity in earnings of unconsolidated affiliates	137,318			119,096			—			(249,774		)	6,640
Operating income	103,247			186,432			219,280			(249,586		)	259,373
Interest expense, net	23,864			35,378			1,187			—			60,429
Earnings from operations before income taxes	79,383			151,054			218,093			(249,586		)	198,944
Income tax expense	24,670			13,924			848			—			39,442
Net earnings	54,713			137,130			217,245			(249,586		)	159,502
Net earnings attributable to noncontrolling interests	—			—			104,789			—			104,789
Net earnings attributable to AmSurg Corp. shareholders	54,713			137,130			112,456			(249,586		)	54,713
Preferred stock dividends	(4,528		)	—			—			—			(4,528		)
Net earnings attributable to AmSurg Corp. common shareholders	$	50,185		$	137,130		$	112,456		$	(249,586	)	$	50,185

Condensed Consolidating Statement of Earnings - For the Three Months Ended June 30, 2014 (In thousands)
	Parent Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Net revenue	$	6,364	$	—	$	276,640	$	(4,777	)	$	278,227
Operating expenses:
Salaries and benefits	15,282		—		68,896		(125		)	84,053
Supply cost	—		—		40,873		—			40,873
Other operating expenses	4,849		—		55,615		(4,652		)	55,812
Transaction costs	3,579		—		—		—			3,579
Depreciation and amortization	815		—		7,621		—			8,436
Total operating expenses	24,525		—		173,005		(4,777		)	192,753
Gain on deconsolidation	1,366		1,366		—		(1,366		)	1,366
Equity in earnings of unconsolidated affiliates	54,639		54,639		—		(108,739		)	539
Operating income	37,844		56,005		103,635		(110,105		)	87,379
Interest expense	6,341		—		551		—			6,892
Earnings from continuing operations before income taxes	31,503		56,005		103,084		(110,105		)	80,487
Income tax expense	12,549		—		249		—			12,798
Net earnings from continuing operations	18,954		56,005		102,835		(110,105		)	67,689
Net earnings from discontinued operations	7		—		476		—			483
Net earnings	18,961		56,005		103,311		(110,105		)	68,172
Net earnings attributable to noncontrolling interests	—		—		49,211		—			49,211
Net earnings attributable to AmSurg Corp. common shareholders	$	18,961	$	56,005	$	54,100	$	(110,105	)	$	18,961
Amounts attributable to AmSurg Corp. common shareholders:
Earnings from continuing operations, net of income tax	$	18,954	$	56,005	$	53,917	$	(110,105	)	$	18,771
Discontinued operations, net of income tax	7		—		183		—			190
Net earnings attributable to AmSurg Corp. common shareholders	$	18,961	$	56,005	$	54,100	$	(110,105	)	$	18,961

Condensed Consolidating Statement of Earnings - For the Six Months Ended June 30, 2014 (In thousands)
	Parent Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Net revenue	$	12,491		$	—	$	534,683	$	(9,386	)	$	537,788
Operating expenses:
Salaries and benefits	29,767			—		136,681		(246		)	166,202
Supply cost	—			—		78,678		—			78,678
Other operating expenses	9,015			—		110,106		(9,140		)	109,981
Transaction costs	3,579			—		—		—			3,579
Depreciation and amortization	1,640			—		15,055		—			16,695
Total operating expenses	44,001			—		340,520		(9,386		)	375,135
Gain on deconsolidation	3,411			3,411		—		(3,411		)	3,411
Equity in earnings of unconsolidated affiliates	102,691			102,691		—		(204,079		)	1,303
Operating income	74,592			106,102		194,163		(207,490		)	167,367
Interest expense	12,793			—		1,059		—			13,852
Earnings from continuing operations before income taxes	61,799			106,102		193,104		(207,490		)	153,515
Income tax expense	25,253			—		527		—			25,780
Net earnings from continuing operations	36,546			106,102		192,577		(207,490		)	127,735
Net earnings (loss) from discontinued operations	(390		)	—		941		—			551
Net earnings	36,156			106,102		193,518		(207,490		)	128,286
Net earnings attributable to noncontrolling interests	—			—		92,130		—			92,130
Net earnings attributable to AmSurg Corp. common shareholders	$	36,156		$	106,102	$	101,388	$	(207,490	)	$	36,156
Amounts attributable to AmSurg Corp. common shareholders:
Earnings from continuing operations, net of income tax	$	36,546		$	106,102	$	101,005	$	(207,490	)	$	36,163
Discontinued operations, net of income tax	(390		)	—		383		—			(7		)
Net earnings attributable to AmSurg Corp. common shareholders	$	36,156		$	106,102	$	101,388	$	(207,490	)	$	36,156

Condensed Consolidating Statement of Cash Flows

Condensed Consolidating Statement of Cash Flows - For the Six Months Ended June 30, 2015 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Cash flows from operating activities:
Net cash flows provided by (used in) operating activities	$	(27,553	)	$	172,907		$	232,423		$	(126,382	)	$	251,395
Cash flows from investing activities:
Acquisitions and related expenses	(51,852		)	(197,718		)	—			53,538			(196,032		)
Acquisition of property and equipment	(4,490		)	(9,424		)	(18,751		)	—			(32,665		)
Purchases of marketable securities	—			—			(1,245		)	—			(1,245		)
Maturities of marketable securities	—			—			2,988			—			2,988
Other	—			(1,441		)	(546		)	—			(1,987		)
Net cash flows used in investing activities	(56,342		)	(208,583		)	(17,554		)	53,538			(228,941		)
Cash flows from financing activities:
Proceeds from long-term borrowings	—			—			7,795			—			7,795
Repayment on long-term borrowings	(4,350		)	—			(5,938		)	—			(10,288		)
Distributions to owners, including noncontrolling interests	—			(15,108		)	(212,307		)	126,382			(101,033		)
Capital contributions	—			51,852			—			(51,852		)	—
Cash dividends for preferred shares	(4,528		)	—			—			—			(4,528		)
Changes in intercompany balances with affiliates, net	444			—			(444		)	—			—
Other financing activities, net	1,636			2,573			1,287			(1,686		)	3,810
Net cash flows provided by (used in) financing activities	(6,798		)	39,317			(209,607		)	72,844			(104,244		)
Net increase (decrease) in cash and cash equivalents	(90,693		)	3,641			5,262			—			(81,790		)
Cash and cash equivalents, beginning of period	134,351			23,471			50,257			—			208,079
Cash and cash equivalents, end of period	$	43,658		$	27,112		$	55,519		$	—		$	126,289

Condensed Consolidating Statement of Cash Flows - For the Six Months Ended June 30, 2014 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Cash flows from operating activities:
Net cash flows provided by operating activities	$	27,919		$	102,284		$	202,508		$	(179,130	)	$	153,581
Cash flows from investing activities:
Acquisitions and related expenses	—			(26,880		)	—			2,443			(24,437		)
Acquisition of property and equipment	(1,949		)	—			(14,126		)	—			(16,075		)
Proceeds from sale of interests in surgery centers	—			2,092			—			—			2,092
Other	(1,259		)	(122		)	—			—			(1,381		)
Net cash flows used in investing activities	(3,208		)	(24,910		)	(14,126		)	2,443			(39,801		)
Cash flows from financing activities:
Proceeds from long-term borrowings	70,000			—			4,246			—			74,246
Repayment on long-term borrowings	(96,358		)	—			(5,968		)	—			(102,326		)
Distributions to owners, including noncontrolling interests	—			(76,846		)	(194,294		)	179,130			(92,010		)
Changes in intercompany balances with affiliates, net	(1,020		)	—			1,020			—			—
Other financing activities, net	(207		)	(528		)	3,559			(2,443		)	381
Net cash flows used in financing activities	(27,585		)	(77,374		)	(191,437		)	176,687			(119,709		)
Net decrease in cash and cash equivalents	(2,874		)	—			(3,055		)	—			(5,929		)
Cash and cash equivalents, beginning of period	6,710			—			44,130			—			50,840
Cash and cash equivalents, end of period	$	3,836		$	—		$	41,075		$	—		$	44,911